Palatin Technologies, Inc

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition	Active, not recruiting	Phase 2	2025-03-06		NCT06565611
Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)	Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcer disease, ulcerative colitis	Active, not recruiting	Phase 2	2025-03-05		NCT05466890

Clinical trials